O	0	11	Subclinical
B-Anatomy	12	19	macular
O	20	28	findings
O	29	31	in
B-Characteristic	32	39	infants
O	40	48	screened
O	49	52	for
B-Disease	53	64	retinopathy
I-Disease	65	67	of
I-Disease	68	79	prematurity
O	80	84	with
B-Diagnostic_tool	85	93	spectral
I-Diagnostic_tool	93	94	-
I-Diagnostic_tool	94	100	domain
I-Diagnostic_tool	101	108	optical
I-Diagnostic_tool	109	118	coherence
I-Diagnostic_tool	119	129	tomography
O	129	130	.

O	132	134	To
O	135	143	evaluate
O	144	155	subclinical
O	156	163	macular
O	164	172	findings
O	173	175	in
B-Characteristic	176	185	premature
I-Characteristic	186	194	patients
O	195	197	at
O	198	202	risk
O	203	205	of
B-Disease	206	217	retinopathy
I-Disease	218	220	of
I-Disease	221	232	prematurity
O	233	234	(
B-Disease	234	237	ROP
O	237	238	)
O	239	243	with
O	244	247	the
O	248	251	use
O	252	254	of
O	255	263	handheld
B-Diagnostic_tool	264	272	spectral
I-Diagnostic_tool	272	273	-
I-Diagnostic_tool	273	279	domain
I-Diagnostic_tool	280	287	optical
I-Diagnostic_tool	288	297	coherence
I-Diagnostic_tool	298	308	tomography
O	309	310	(
B-Diagnostic_tool	310	312	SD
I-Diagnostic_tool	312	313	-
I-Diagnostic_tool	313	316	OCT
O	316	317	)
O	317	318	.

O	319	330	Prospective
O	330	331	,
O	332	345	observational
O	346	350	case
O	351	357	series
O	357	358	.

O	359	364	Forty
O	364	365	-
O	365	369	nine
B-Characteristic	370	381	prematurely
I-Characteristic	382	386	born
I-Characteristic	387	395	neonates
O	395	396	.

O	397	402	Forty
O	402	403	-
O	403	407	nine
B-Characteristic	408	415	infants
O	416	420	were
O	421	427	imaged
O	428	433	using
O	434	435	a
O	436	444	handheld
B-Diagnostic_tool	445	447	SD
I-Diagnostic_tool	447	448	-
I-Diagnostic_tool	448	451	OCT
O	451	452	.

O	453	459	Images
O	460	464	were
O	465	473	acquired
O	474	476	in
B-Characteristic	477	487	nonsedated
I-Characteristic	488	495	infants
O	496	498	in
O	499	502	the
O	503	511	neonatal
O	512	521	intensive
O	522	526	care
O	527	531	unit
O	532	533	(
O	533	537	NICU
O	537	538	)
O	538	539	.

O	540	544	Some
O	545	553	patients
O	554	558	were
O	559	567	followed
O	568	571	and
O	572	580	reimaged
O	581	585	over
O	586	589	the
O	590	596	course
O	597	599	of
O	600	607	several
O	608	613	weeks
O	613	614	.

O	615	616	A
O	617	622	total
O	623	625	of
O	626	629	300
O	630	635	total
O	636	642	images
O	643	647	were
O	648	656	acquired
O	657	660	and
O	661	670	evaluated
O	671	674	for
B-Disease	675	682	cystoid
I-Disease	683	690	macular
I-Disease	691	696	edema
O	697	698	(
B-Disease	698	701	CME
O	701	702	)
O	703	706	and
O	707	718	persistence
O	719	721	of
B-Symptom	722	727	inner
I-Symptom	728	735	retinal
I-Symptom	736	742	layers
O	742	743	.

O	744	746	In
O	747	751	vivo
O	752	765	determination
O	766	768	of
B-Anatomy	769	775	foveal
I-Anatomy	776	783	retinal
O	784	794	lamination
O	794	795	,
O	796	801	image
O	802	810	analysis
O	810	811	,
O	812	815	and
O	816	824	clinical
O	825	836	observation
O	836	837	.

O	838	839	A
O	840	845	total
O	846	848	of
O	849	852	241
O	853	854	(
O	854	856	80
O	856	857	%
O	857	858	)
O	859	861	of
O	862	865	the
O	866	872	images
O	873	877	from
O	878	880	46
O	881	889	patients
O	890	894	were
O	895	901	usable
O	902	903	(
O	903	910	defined
O	911	913	as
O	914	920	having
O	921	926	scans
O	927	934	passing
O	935	942	through
O	943	946	the
B-Anatomy	947	952	fovea
O	953	957	with
O	958	965	clearly
O	966	978	identifiable
B-Anatomy	979	986	retinal
I-Anatomy	987	993	layers
O	993	994	)
O	994	995	.

B-Symptom	996	1007	Persistence
I-Symptom	1008	1010	of
I-Symptom	1011	1012	1
I-Symptom	1013	1015	or
I-Symptom	1016	1020	more
I-Symptom	1021	1026	inner
I-Symptom	1027	1034	retinal
I-Symptom	1035	1041	layers
O	1042	1045	was
O	1046	1050	seen
O	1051	1053	in
O	1054	1056	43
O	1057	1059	of
O	1060	1063	the
O	1064	1072	patients
O	1073	1077	with
O	1078	1084	usable
O	1085	1091	images
O	1092	1093	(
O	1093	1095	93
O	1095	1096	%
O	1096	1097	)
O	1097	1098	.

O	1099	1101	Of
O	1102	1105	the
O	1106	1114	patients
O	1115	1119	with
O	1120	1122	at
O	1123	1128	least
O	1129	1130	1
B-Symptom	1131	1141	persistent
I-Symptom	1142	1147	layer
O	1147	1148	,
O	1149	1151	17
O	1151	1152	,
O	1153	1154	4
O	1154	1155	,
O	1156	1157	8
O	1157	1158	,
O	1159	1161	12
O	1161	1162	,
O	1163	1166	and
O	1167	1168	1
O	1168	1169	,
O	1170	1173	had
O	1174	1175	a
O	1176	1183	maximum
B-Characteristic	1184	1187	ROP
I-Characteristic	1188	1193	stage
O	1194	1196	of
O	1197	1198	0
O	1198	1199	,
O	1200	1201	1
O	1201	1202	,
O	1203	1204	2
O	1204	1205	,
O	1206	1207	3
O	1207	1208	,
O	1209	1212	and
O	1213	1215	4A
O	1215	1216	,
O	1217	1229	respectively
O	1229	1230	.

B-Disease	1231	1238	Cystoid
I-Disease	1239	1246	macular
I-Disease	1247	1252	edema
O	1253	1256	was
O	1257	1261	seen
O	1262	1264	in
O	1265	1267	25
O	1268	1270	of
O	1271	1274	the
O	1275	1277	46
O	1278	1286	patients
O	1287	1288	(
O	1288	1290	54
O	1290	1291	%
O	1291	1292	)
O	1293	1299	during
O	1300	1301	1
O	1302	1304	or
O	1305	1309	more
O	1310	1317	imaging
O	1318	1326	sessions
O	1326	1327	.

B-Disease	1328	1335	Cystoid
I-Disease	1336	1343	macular
I-Disease	1344	1349	edema
O	1350	1353	was
O	1354	1361	present
O	1362	1364	in
O	1365	1366	9
O	1366	1367	,
O	1368	1369	1
O	1369	1370	,
O	1371	1372	5
O	1372	1373	,
O	1374	1375	9
O	1375	1376	,
O	1377	1380	and
O	1381	1382	1
O	1383	1390	patient
O	1391	1395	with
O	1396	1403	maximum
B-Characteristic	1404	1407	ROP
I-Characteristic	1408	1413	stage
O	1414	1416	of
O	1417	1418	0
O	1418	1419	,
O	1420	1421	1
O	1421	1422	,
O	1423	1424	2
O	1424	1425	,
O	1426	1427	3
O	1427	1428	,
O	1429	1432	and
O	1433	1435	4A
O	1435	1436	,
O	1437	1449	respectively
O	1449	1450	.

O	1451	1454	Our
O	1455	1459	data
O	1460	1467	suggest
O	1468	1473	there
O	1474	1476	is
B-Symptom	1477	1488	persistence
I-Symptom	1489	1491	of
I-Symptom	1492	1497	inner
I-Symptom	1498	1505	retinal
I-Symptom	1506	1512	layers
O	1513	1515	in
B-Characteristic	1516	1525	premature
I-Characteristic	1526	1533	infants
O	1534	1544	regardless
O	1545	1547	of
B-Characteristic	1548	1555	maximal
I-Characteristic	1556	1559	ROP
I-Characteristic	1560	1565	stage
O	1565	1566	.

O	1567	1578	Subclinical
B-Disease	1579	1582	CME
O	1583	1585	is
O	1586	1590	seen
O	1591	1593	in
B-Characteristic	1594	1603	premature
I-Characteristic	1604	1611	infants
O	1611	1612	;
O	1613	1620	however
O	1620	1621	,
B-Disease	1622	1625	CME
O	1626	1630	does
O	1631	1634	not
O	1635	1641	appear
O	1642	1644	to
O	1645	1647	be
O	1648	1658	correlated
O	1659	1663	with
B-Characteristic	1664	1667	ROP
I-Characteristic	1668	1673	stage
O	1673	1674	.

O	1675	1679	This
O	1680	1688	suggests
O	1689	1693	that
O	1694	1699	there
O	1700	1703	may
O	1704	1706	be
O	1707	1712	other
O	1713	1719	causes
O	1720	1723	for
O	1724	1727	the
B-Disease	1728	1731	CME
O	1732	1736	seen
O	1737	1739	in
O	1740	1744	this
O	1745	1752	patient
O	1753	1763	population
O	1763	1764	.

O	1765	1769	Hand
O	1769	1770	-
O	1770	1774	held
B-Diagnostic_tool	1775	1777	SD
I-Diagnostic_tool	1777	1778	-
I-Diagnostic_tool	1778	1781	OCT
I-Diagnostic_tool	1782	1789	imaging
O	1790	1792	is
O	1793	1794	a
O	1795	1801	viable
O	1802	1811	technique
O	1812	1815	for
O	1816	1826	evaluating
B-Symptom	1827	1838	subclinical
I-Symptom	1839	1846	macular
I-Symptom	1847	1855	findings
O	1856	1858	in
B-Characteristic	1859	1868	premature
I-Characteristic	1869	1876	infants
O	1876	1877	,
O	1878	1886	although
O	1887	1893	larger
O	1894	1902	datasets
O	1903	1906	are
O	1907	1913	needed
O	1914	1918	from
O	1919	1927	multiple
O	1928	1935	centers
O	1936	1938	to
O	1939	1946	further
O	1947	1955	evaluate
O	1956	1959	the
O	1960	1976	generalizability
O	1977	1979	of
O	1980	1985	these
O	1986	1994	findings
O	1994	1995	.

O	1996	1999	The
O	2000	2006	author
O	2006	2007	(
O	2007	2008	s
O	2008	2009	)
O	2010	2014	have
O	2015	2017	no
O	2018	2029	proprietary
O	2030	2032	or
O	2033	2043	commercial
O	2044	2052	interest
O	2053	2055	in
O	2056	2059	any
O	2060	2069	materials
O	2070	2079	discussed
O	2080	2082	in
O	2083	2087	this
O	2088	2095	article
O	2095	2096	.
